Revvity(REVVITY INC)宣布,计划收购Human Cell Design公司。此举旨在推动用于代谢疾病药物发现的人源相关细胞模型向前发展。通过这次并购,Revvity期望进一步强化其在生命科学与诊断领域的布局,特别是在药物研发链条中的关键环节——细胞模型的建立与应用方面,为代谢疾病治疗方案的探索提供更具生理相关性的工具和支持。
Revvity(REVVITY INC)宣布,计划收购Human Cell Design公司。此举旨在推动用于代谢疾病药物发现的人源相关细胞模型向前发展。通过这次并购,Revvity期望进一步强化其在生命科学与诊断领域的布局,特别是在药物研发链条中的关键环节——细胞模型的建立与应用方面,为代谢疾病治疗方案的探索提供更具生理相关性的工具和支持。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.